 Print page |
 Email page |
| FOR IMMEDIATE RELEASE |
October 14, 2009 |
ATA PRESIDENT INSTALLED
Terry F. Davies, M.D., Installed as American Thyroid Association (ATA) President for 2009-2010 Term
Terry F. Davies, M.D., an internationally recognized expert in thyroid disease, has been installed as President of the American Thyroid Association (ATA) during the 80th Annual Meeting of the ATA held in Palm Beach, Florida September 23-27, 2009.
Terry F. Davies, M.D., an internationally recognized expert in thyroid disease, has been installed as President of the American Thyroid Association (ATA) during the 80th Annual Meeting of the ATA held in Palm Beach, Florida September 23-27, 2009.
Dr. Davies has a long and distinguished record of significant contributions to understanding the endocrine physiology and pathology. He has published more than 400 scientific papers, chapters and books, mostly in the area of thyroid disease at a basic level, in the areas of immunology and genetics, and in the clinical arena of autoimmune thyroid disease and pregnancy. Although Dr. Davies, as a clinician, is often included in many lists of “Best Doctors,” the Davies Laboratory also remains one of the world’s pre-eminent sites for autoimmune thyroid disease research as evidenced by his extensive support from the National Institutes of Health and the Veterans’ Administration.
Dr. Davies has received many honors in his career, including the Pitt Rivers Lecture of the British Endocrine Society and the Sidney Ingbar Distinguished Lecture of the American Thyroid Association. Dr. Davies is a Fellow of the Royal College of Physicians and is a member of the American Association of Physicians.
“I am honored to have been elected to serve as ATA President,” said Dr. Davies, Florence and Theodore Baumritter Professor of Medicine at the Mount Sinai School of Medicine in New York and the Director of the Division of Endocrinology and Metabolism at the James J. Peters VA Medical Center “The ATA is an exceptional organization and I look forward to working alongside my colleagues on the Board of Directors to continue improving the lives of patients with thyroid diseases, especially the large number of women who get thyroid disorders.”
